Our Impact

See how we educate the public, professionals, legislators and the media about the impact of benzodiazepines. 

Some of the media outlets we have assisted…

Our Outreach

Media

An integral part of Benzodiazepine Information Coalition’s (BIC) outreach efforts includes awareness and education via many well-known media outlets and publications. Members of our Board of Directors, General Advisory Board, and Medical Advisory Board are frequently contacted for interview or commentary in various projects. BIC also maintains a close working relationship with the large benzodiazepine-affected community and we often serve as a vital bridge, connecting journalists and other media outlets with patients willing to share their stories in print or on film. Our numerous media contributions, to date, are detailed below. Contact us for any media inquiries.

Events

Part of our impact includes outreach to professionals and the public about the potential harms of benzodiazepines taken as prescribed. We attend conferences, speak and have events to raise awareness.

Research

Members of our coalition dedicate their time to research benzodiazepines and their potential for injury.

Media Outreach

The Deadly Worst Case Scenario for America's Xanax Obsession

Maia Szalavitz, Vice

Seidman: An epidemic — and it’s not opioids

Carrie Seidman, Sarasota Herald Tribune

This Is Why Xanax Is Blowing Up in America

Maia Szalavitz, Vice

Dangers of rising benzo prescriptions raise alarms of next drug crisis

NBC News with Lester Holt

These Pills Could Be Next U.S. Drug Epidemic, Public Health Officials Say

Christine Vestal, Pew Trusts

Talk Radio Europe July 11, 2011

Stacy Pinkerton

Overprescribed Podcast with Dr. Christy Huff

Overprescribed with Mika Pollack

A Quiet Drug Problem Among the Elderly

Paula Span, New York Times

With benzos, a doctor discovers ease of dependency, ordeal of withdrawal

M.J. Tidwell, Daily Hampshire Gazette

Cause-of-death finding bolsters cover-up claim in Fremont County jail inmate’s death

Lance Benzel, The Gazette

Too Many Meds? America’s Love Affair With Prescription Medication

Teresa Carr, Consumer Reports

I Tried to Get Off Ativan

Harriet Brown, Vice

A New Patient-Initiated Coalition Battles Benzos

Allen Frances, M.D., Rehabs.com

Our Research

How Chronic Administration of Benzodiazepines Leads To Unexplained Chronic Illnesses: A Hypothesis

What do hypnotics cost hospitals and healthcare?, Daniel Kripke, M.D.

Position Statement on the Use of Benzodiazepine in Patients Receiving Buprenorphine Treatment, Christy Huff, M.D., A.J. Reid Finlayson, M.D.

Study examines factors that boost suicide risk for doctors, A.J. Reid Finlayson, M.D.

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit, Daniel F. Kripke, M.D.

Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem, Daniel F. Kripke, M.D.

Social Networking and Benzodiazepine Withdrawal: The Reality of Dependence and Necessity of Support, Catherine Pittman, Ph.D.